Longevity & AgingResearch PaperPaywall

CPAP Cuts Sleepiness but Not Fatigue in Stroke Patients with Sleep Apnea

A large prospective study finds high CPAP compliance reduces post-stroke sleepiness, but fatigue persists regardless of treatment adherence.

Sunday, June 28, 2026 3 views
Published in J Stroke Cerebrovasc Dis
A stroke patient sleeping with a CPAP mask in a dim hospital room, bedside monitor glowing softly, dawn light at the window.

Summary

Obstructive sleep apnea (OSA) affects roughly 70% of stroke patients, yet systematic screening remains rare in post-stroke care. This Danish multi-center cohort study screened over 1,500 ischemic stroke and TIA patients for OSA, enrolling 648 CPAP-eligible individuals. Patients were assessed for sleepiness and fatigue at baseline and seven to eight months post-stroke. Those with high CPAP compliance showed significant reductions in daytime sleepiness compared to low-compliance patients. However, fatigue levels declined across all groups with no meaningful difference between compliance tiers, suggesting fatigue after stroke has drivers beyond OSA alone. The findings reinforce calls for routine OSA screening after stroke and highlight that sleepiness and post-stroke fatigue are distinct, independently mediated symptoms requiring separate therapeutic strategies.

Detailed Summary

Post-stroke fatigue and sleepiness are debilitating symptoms that impair rehabilitation and quality of life, yet their underlying mechanisms are not fully understood. Obstructive sleep apnea, present in approximately 70% of stroke survivors, is a plausible contributor to both. Despite this, systematic OSA screening and CPAP treatment are not standard components of post-stroke care in most health systems.

This prospective, multi-center cohort study conducted in Denmark screened 1,518 ischemic stroke and TIA patients using respiratory polygraphy. Of these, 648 met the CPAP-eligibility threshold (Apnea-Hypopnea Index ≥15). Sleepiness and fatigue were measured at baseline and at seven to eight months post-stroke using the Epworth Sleepiness Scale (ESS) and Visual Analogue Scale-Fatigue (VAS-F). CPAP compliance was categorized as high (≥70% of nights with >4 hours use), moderate (50–69%), or low (<50%), with Poisson regression used to compare outcomes.

The key finding was a clear dissociation between sleepiness and fatigue. High CPAP compliance was significantly associated with reduced daytime sleepiness relative to low compliance (p<0.001). By contrast, fatigue declined across all compliance groups with no statistically significant difference between them, indicating that CPAP adherence does not differentially improve post-stroke fatigue.

These results have meaningful implications for clinical practice. They support universal OSA screening after stroke and show that encouraging CPAP use can meaningfully address sleepiness—a recoverable symptom. However, clinicians should not expect CPAP alone to resolve post-stroke fatigue, which likely involves neurological, inflammatory, and psychological mechanisms independent of sleep-disordered breathing.

Notable caveats include a 49% loss to follow-up, which may introduce selection bias, and the observational design limits causal inference. Fatigue's multifactorial nature warrants dedicated intervention trials.

Key Findings

  • High CPAP compliance significantly reduced daytime sleepiness vs. low compliance in post-stroke OSA patients (p<0.001).
  • Post-stroke fatigue declined across all CPAP compliance groups with no significant difference between groups.
  • OSA affects ~70% of stroke patients; 648 of 1,518 screened met CPAP-eligibility criteria.
  • Sleepiness and fatigue are distinct post-stroke symptoms requiring separate therapeutic approaches.
  • Findings support routine OSA screening as part of standard post-stroke care protocols.

Methodology

Prospective multi-center cohort study in Denmark screening 1,518 ischemic stroke and TIA patients via respiratory polygraphy. CPAP-eligible patients (AHI ≥15) were assessed with ESS and VAS-F at baseline and 7–8 months post-stroke. Poisson regression compared outcomes across low, moderate, and high CPAP compliance groups.

Study Limitations

A 49% loss to follow-up risks selection bias, potentially skewing results toward more motivated or healthier patients. The observational design precludes definitive causal conclusions about CPAP's effect on sleepiness or fatigue. Fatigue's multifactorial etiology—including neurological, inflammatory, and psychosocial components—may mask any OSA-specific contribution.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: